Study of JYP0015 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

China

Beijing Cancer Hospital, Beijing, Beijing Municipality